Evidence-Based Medicine Guidelines
Targeted therapy for advanced renal cell carcinoma
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Targeted Therapy for Advanced Renal Cell Carcinoma." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/451658/all/_________Targeted_therapy_for_advanced_renal_cell_carcinoma______.
Targeted therapy for advanced renal cell carcinoma. Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/EBMG/451658/all/_________Targeted_therapy_for_advanced_renal_cell_carcinoma______. Accessed March 24, 2025.
Targeted therapy for advanced renal cell carcinoma. (2025). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/451658/all/_________Targeted_therapy_for_advanced_renal_cell_carcinoma______
Targeted Therapy for Advanced Renal Cell Carcinoma [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. [cited 2025 March 24]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/451658/all/_________Targeted_therapy_for_advanced_renal_cell_carcinoma______.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Targeted therapy for advanced renal cell carcinoma
ID - 451658
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/451658/all/_________Targeted_therapy_for_advanced_renal_cell_carcinoma______
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
